high amylose starch;
Hylon VII;
amylose;
crosslinks;
swelling;
excipient;
slow release;
solid state NMR;
CP/MAS NMR;
double helices;
D O I:
10.1016/S0141-8130(99)00082-3
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
a controlled release excipient based on sodium trimetaphosphate (STMP) crosslinked high amylose starch has been examined by C-13 CP/MAS NMR. The dry excipient powder is pressed to a hard tablet whose volume increase in H2O runs parallel to the STMP concentration used. The known polymorph resonances of single helix 'V' starch (hydrated) and double helix 'B' starch (hydrated) both contribute to the spectrum corresponding to the swollen tablet. The wet tablet when loaded with a pharmaceutical agent provides a near zero-order release profile for up to 20 h. The swelling and drug release behaviour is explained in terms of self-assembly of the STMP treated starch nanomolecular particles. These particles are drawn together by "self-assembly" due to formation of amylose double helices as water penetrates the tablet. An optimum level of chemical crosslinking ensures the integrity of the swollen tablet whose sponge-like structure enclosed by a membranous surface is responsible for sustained release. (C) 1999 Elsevier Science B.V. All rights reserved.